Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $850.82 | 13 | 89.5% |
| Education | $99.99 | 1 | 10.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $342.02 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $218.35 | 2 | $0 (2024) |
| Lilly USA, LLC | $211.05 | 2 | $0 (2024) |
| Esperion Therapeutics, Inc. | $96.36 | 1 | $0 (2022) |
| Penumbra, Inc. | $49.83 | 1 | $0 (2021) |
| Boston Scientific Corporation | $33.20 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $273.15 | 5 | AstraZeneca Pharmaceuticals LP ($118.36) |
| 2023 | $135.56 | 2 | Lilly USA, LLC ($105.35) |
| 2022 | $392.28 | 5 | Medtronic, Inc. ($295.92) |
| 2021 | $149.82 | 2 | AstraZeneca Pharmaceuticals LP ($99.99) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | Boston Scientific Corporation | OptiCross 35 (Device) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: OptiCross_PI | ||||||
| 08/29/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: EndoVenous Therapies | ||||||
| 08/21/2024 | Boston Scientific Corporation | OptiCross 35 (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: OptiCross_PI | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $118.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $105.70 | General |
| Category: Diabetes | ||||||
| 05/12/2023 | Medtronic, Inc. | HAWKONE (Device) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: Directional Atherectomy Devices | ||||||
| 04/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $105.35 | General |
| Category: Diabetes | ||||||
| 12/24/2022 | Medtronic, Inc. | IN.PACT ADMIRAL (Device) | Food and Beverage | In-kind items and services | $124.59 | General |
| Category: Drug-Coated Balloons | ||||||
| 11/15/2022 | Medtronic, Inc. | SPIDERFX (Device) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Embolic Protection Devices | ||||||
| 11/08/2022 | Medtronic, Inc. | SILVERHAWK (Device) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Directional Atherectomy Devices | ||||||
| 11/02/2022 | Medtronic, Inc. | SILVERHAWK (Device) | Food and Beverage | In-kind items and services | $130.77 | General |
| Category: Directional Atherectomy Devices | ||||||
| 10/27/2022 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $96.36 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/24/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/25/2021 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $49.83 | General |
| Category: Peripheral Intervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 947 | 1,268 | $954,603 | $200,360 |
| 2022 | 7 | 621 | 892 | $946,029 | $209,874 |
| 2021 | 3 | 207 | 226 | $34,250 | $14,405 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 43 | 129 | $490,200 | $111,722 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 400 | 400 | $237,943 | $44,603 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 344 | 579 | $173,400 | $34,953 | 20.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 135 | 135 | $43,137 | $7,058 | 16.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $5,540 | $1,072 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $4,384 | $953.04 | 21.7% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2022 | 50 | 155 | $589,205 | $139,202 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 262 | 262 | $155,697 | $29,608 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 186 | 350 | $104,545 | $21,316 | 20.4% |
| 36466 | Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance | Office | 2022 | 13 | 13 | $54,600 | $12,924 | 23.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 70 | 70 | $20,126 | $2,913 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 25 | $9,984 | $2,148 | 21.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 17 | 17 | $11,872 | $1,764 | 14.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 126 | 145 | $20,155 | $8,726 | 43.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 65 | $13,455 | $5,548 | 41.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 16 | 16 | $640.00 | $130.78 | 20.4% |
About Michael Lee, APRN
Michael Lee, APRN is a Family healthcare provider based in Tavares, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2020. The National Provider Identifier (NPI) number assigned to this provider is 1487284824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Lee, APRN has received a total of $950.81 in payments from pharmaceutical and medical device companies, with $273.15 received in 2024. These payments were reported across 14 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($850.82).
As a Medicare-enrolled provider, Lee has provided services to 1,775 Medicare beneficiaries, totaling 2,386 services with total Medicare billing of $424,639. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Tavares, FL
- Active Since 01/24/2020
- Last Updated 01/24/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1487284824
Products in Payments
- MOUNJARO (Drug) $211.05
- SILVERHAWK (Device) $142.90
- IN.PACT ADMIRAL (Device) $124.59
- FARXIGA (Drug) $118.36
- BRILINTA (Drug) $99.99
- NEXLIZET (Drug) $96.36
- Indigo System (Device) $49.83
- OptiCross 35 (Device) $33.20
- HAWKONE (Device) $30.21
- SPIDERFX (Device) $28.43
- VENASEAL (Device) $15.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Tavares
Julie Voiselle, Arnp, ARNP
Family — Payments: $6,251
Isabel Denis, Fnp, FNP
Family — Payments: $3,515
Genesis Guerrero
Family — Payments: $2,785
Mr. Bryan Mccall, Np-C, NP-C
Family — Payments: $1,191
Elizabeth Barger, Arnp, ARNP
Family — Payments: $820.10
Hiam Collar, Aprn, APRN
Family — Payments: $797.90